Fundraising FoxPixium Vision
6 known investors
Find your way into Pixium Vision
Sign up to see every warm intro you have to Pixium Vision
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pixium Vision team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pixium Vision SA developed the PRIMA System, an implantable device for treating late-stage macular degeneration, and ran clinical trials in Europe. Its assets, including the ongoing clinical trials, have been acquired by Science Corporation.
Investors · 6
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries A extensionNov 2013
Sofinnova Partners (lead), Abingworth LLP, Bpifrance, Omnes Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Pixium Vision do?
- Pixium Vision SA developed the PRIMA System, an implantable device for treating late-stage macular degeneration, and ran clinical trials in Europe. Its assets, including the ongoing clinical trials, have been acquired by Science Corporation.
- Who are Pixium Vision's investors?
- Pixium Vision's investors include Agoranov, Sofinnova Partners, Abingworth, Bpifrance, Omnes Capital.